Advanced Biomed (ADVB) Accounts Payables (2024 - 2026)

Advanced Biomed has disclosed Accounts Payables across 3 years of filings, most recently posting $10000.0 for Q1 2026.

• Accounts Payables for Q1 2026 came in at $10000.0, down 99.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $10000.0 (down 99.75% YoY), and the FY2025 annual result was $1.9 million, up 202.28% from the prior year.
• Accounts Payables came in at $10000.0 for Q1 2026 at Advanced Biomed, down from $369293.0 in the prior quarter.
• In the past five years, Accounts Payables ranged from a high of $4.0 million in Q1 2025 to a low of $10000.0 in Q1 2026.
• The 3-year median for Accounts Payables is $620476.0 (2024), against an average of $1.2 million.
• Across the five-year window, Accounts Payables soared 202.28% in 2025 and plunged 99.75% in 2026, its largest moves.
• Advanced Biomed's Accounts Payables stood at $617865.0 in 2024, then tumbled by 40.23% to $369293.0 in 2025, then tumbled by 97.29% to $10000.0 in 2026.
• The last three Accounts Payables figures came in at $10000.0 (Q1 2026), $369293.0 (Q4 2025), and $817020.0 (Q3 2025), per Business Quant data.